Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism

被引：0
|
作者：
Piotr Kuczera
Marcin Adamczak
Andrzej Więcek
机构：
[1] Transplantation and Internal Medicine,Department of Nephrology
[2] Medical University of Silesia,undefined
来源：
BMC Nephrology | / 17卷
关键词：
Secondary hyperparathyroidism; Hemodialysis; Cinacalcet; Sclerostin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Comparative Effectiveness of Paricalcitol versus Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
    Schumock, Glen T.
    Walton, Surrey M.
    Lee, Todd A.
    Marx, Steven E.
    Audhya, Paul
    Andress, Dennis L.
    NEPHRON CLINICAL PRACTICE, 2011, 117 (02): : C151 - C159
  • [42] Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Wiecek, Andrzej
    CLINICAL ENDOCRINOLOGY, 2014, 80 (04) : 607 - 612
  • [43] A Novel Dose Regimen of Cinacalcet in the Treatment of Severe Hyperparathyroidism in Hemodialysis Patients
    Al-Hilali, Nabieh
    Hussain, Nasser
    Kawy, Yasser A.
    Al-Azmi, Mohmmed
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2011, 22 (03) : 448 - 455
  • [44] Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism
    Bergua, C.
    Torregrosa, J.-V.
    Cofan, F.
    Oppenheimer, F.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2254 - 2255
  • [45] Cinacalcet for secondary hyperparathyroidism in ESRD patients
    Kirby R.
    Nature Clinical Practice Nephrology, 2006, 2 (1): : 8 - 9
  • [46] Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients
    Delanaye, Pierre
    Krzesinski, Jean-Marie
    Warling, Xavier
    Moonen, Martial
    Smelten, Nicole
    Medart, Laurent
    Bruyere, Olivier
    Reginster, Jean-Yves
    Pottel, Hans
    Cavalier, Etienne
    NEPHRON CLINICAL PRACTICE, 2014, 128 (1-2): : 127 - 134
  • [47] Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
    Giovanni Conzo
    Alessandra F Perna
    Salvatore Napolitano
    Claudio Mauriello
    Claudio Gambardella
    Ersilia Satta
    Giuseppe Ciancia
    Giovanbattista Capasso
    Luigi Santini
    Journal of Medical Case Reports, 6 (1)
  • [48] A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
    Hironori Nakamura
    Masanori Tokumoto
    Mariko Anayama
    Shigekazu Kurihara
    Yasushi Makino
    Katsuhiko Tamura
    Masaki Nagasawa
    CEN Case Reports, 2022, 11 : 254 - 258
  • [49] A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
    Nakamura, Hironori
    Tokumoto, Masanori
    Anayama, Mariko
    Kurihara, Shigekazu
    Makino, Yasushi
    Tamura, Katsuhiko
    Nagasawa, Masaki
    CEN CASE REPORTS, 2022, 11 (02) : 254 - 258
  • [50] Effect of secondary hyperparathyroidism treatment with cinacalcet on selected adipokines and markers of endothelial injury in hemodialysis patients: a preliminary report
    Hryszko, Tomasz
    Brzosko, Szymon
    Rydzewska-Rosolowska, Alicja
    Koc-Zorawska, Ewa
    Naumnik, Beata
    Mysliwiec, Michal
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2012, 122 (04): : 148 - 153
12345